In vitro immunologic properties of human umbilical cord perivascular cells

Cytotherapy

Volumn 10, Issue 2, 2008, Pages 174-181

  Ennis, J ^a   Gotherstrom C ^b   Le Blanc, K ^b   Davies, J E ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Immunosuppression; Mesenchymal stromal cells; MSC; Perivascular; Umbilical cord

Indexed keywords

CD45 ANTIGEN; HEPARIN; INTERLEUKIN 2 RECEPTOR ALPHA;

ALLOIMMUNITY; ANTIGEN EXPRESSION; ARTICLE; CELL ISOLATION; COCULTURE; CONTROLLED STUDY; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; IMMUNOPHENOTYPING; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; LYMPHOCYTE ACTIVATION; LYMPHOCYTE COUNT; LYMPHOCYTE PROLIFERATION; MESENCHYMAL STEM CELL; MIXED LYMPHOCYTE CULTURE; NORMAL HUMAN; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; T LYMPHOCYTE; UMBILICAL CORD; UMBILICAL CORD BLOOD; ANALYSIS OF VARIANCE; CELL COUNT; CELL LINE; CELL PROLIFERATION; CYTOLOGY; IMMUNOLOGY; METABOLISM; VASCULARIZATION;

ANALYSIS OF VARIANCE; ANTIGENS, CD45; CELL COUNT; CELL LINE; CELL PROLIFERATION; COCULTURE TECHNIQUES; HUMANS; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; LYMPHOCYTE ACTIVATION; LYMPHOCYTE CULTURE TEST, MIXED; T-LYMPHOCYTES; UMBILICAL CORD;

EID: 42949100114     PISSN: 14653249     EISSN: 14772566     Source Type: Journal    
DOI: 10.1080/14653240801891667     Document Type: Article

References (45)

1. Sarugaser, R., Lickorish, D. and Baksh, D. (2005) Human umbilical cord perivascular (HUCPV) cells: A source of mesenchymal progenitors. Stem Cells, 23, pp. 220-229.
2. da Silva, ML, Chagastelles, PC and Nardi, NB. (2006) Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J Cell Sci, 119, pp. 2204-2213.
3. Shi, S. and Gronthos, S. (2003) Perivascular niche of postnatal mesenchymal stem cells in human bone marrow and dental pulp. J Bone Miner Res, 18, pp. 696-704.
4. McElreavey, KD, Irvine, AI, Ennis, KT and McLean, WH. (1991) Isolation, culture and characterisation of fibroblast-like cells derived from the Wharton's jelly portion of human umbilical cord. Biochem Soc Trans, 19, p. 29S.
5. Mitchell, KE, Weiss, ML and Mitchell, BM (2003) Matrix cells from Wharton's jelly form neurons and glia. Stem Cells, 21, pp. 50-60.
6. Medicetty, S., Bledsoe, AR and Fahrenholtz, CB (2004) Transplantation of pig stem cells into rat brain: Proliferation during the first 8 weeks. Exp Neurol, 190, pp. 32-41.
7. Weiss, ML, Medicetty, S. and Bledsoe, AR (2005) Human umbilical cord matrix stem cells: Preliminary characterization and effect of transplantation in a rodent model of Parkinson's disease. Stem Cells, 24, pp. 781-792.
8. Weiss, ML, Mitchell, KE and Hix, JE (2003) Transplantation of porcine umbilical cord matrix cells into the rat brain. Exp Neurol, 182, pp. 288-299.
9. Naughton, B., Roman, J San and Liu, K. (1997) Cells isolated from Wharton's jelly of the human umbilical cord develop a cartilage phenotype when treated with TGF-beta in vitro. FASEB J, 11, p. 19.
10. Bailey, MM, Wang, L. and Bode, CJ (2007) A comparison of human umbilical cord matrix stem cells and temporomandibular joint condylar chondrocytes for tissue engineering temporomandibular joint condylar cartilage. Tissue Eng, 13, pp. 2003-2010.
11. Conconi, MT, Burra, P. and Di, LR (2006) CD105(+) cells from Wharton's jelly show in vitro and in vivo myogenic differentiative potential. Int J Mol Med, 18, pp. 1089-1096.
12. Schmidt, D., Mol, A. and Odermatt, B. (2006) Engineering of biologically active living heart valve leaflets using human umbilical cord-derived progenitor cells. Tissue Eng, 12, pp. 3223-3232.
13. Ennis, J. (2006) Human Umbilical Cord Perivascular Cells (HUCPVCs): Verification of their Provenance and Immunocharacterization, Institute of Biomaterials and Biomedical Engineering, University of Toronto, Toronto
14. Baksh, D., Yao, R. and Tuan, R. (2007) Comparison of proliferative and multilineage differentiation potential of human mesenchymal stem cells derived from umbilical cord and bone marrow. Stem Cells, 45, pp. 99-106.
15. Gomez-Aristizabal, A., Hanoun, L., Sarugaser, R. and Davies, J. Human Umbilical Cord Perivascular Cells (HUCPVCs) Display High Proliferative Capacity but no Telomerase Activity. International Society for Stem Cell Research
16. Sarugaser, R., Hanoun, L. and Kwong, F. (2006) Human Umbilical Cord Perivascular Cell (HUCPVC) Clones Determine Mesenchymal Stem Cell Identity, International Society for Stem Cell Research, Deerfield, IL
17. Uccelli, A., Moretta, L. and Pistoia, V. (2006) Immunoregulatory function of mesenchymal stem cells. Eur J Immunol, 36, pp. 2566-2573.
18. Blanc, K Le and Ringden, O. (2005) Immunobiology of human mesenchymal stem cells and future use in hematopoietic stem cell transplantation. Biol Blood Marrow Transplant, 11, pp. 321-334.
19. Tse, W., Pendleton, J. and Beyer, W. (2003) Suppression of allogeneic T-cell proliferation by human marrow stromal cells: Implications in transplantation. Transplantation, 75, pp. 389-397.
20. Blanc, K Le, Tammik, C. and Rosendahl, K. (2003) HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells. Exp Hematol, 31, pp. 890-896.
21. Deans, RJ and Moseley, AB. (2000) Mesenchymal stem cells: Biology and potential clinical uses. Exp Hematol, 28, pp. 875-884.
22. Blanc, K. Le (2003) Immunomodulatory effects of fetal and adult mesenchymal stem cells. Cytotherapy, 5, pp. 485-489.
23. Nicola, M Di, Carlo-Stella, C. and Magni, M. (2002) Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood, 99, pp. 3838-3843.
24. Blanc, K Le, Tammik, L. and Sundberg, B. (2003) Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex. Scand J Immunol, 57, pp. 11-20.
25. Bartholomew, A., Sturgeon, C. and Siatskas, M. (2002) Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol, 30, pp. 42-48.
26. Beggs, KJ, Lyubimov, A. and Borneman, JN (2006) Immunologic consequences of multiple, high-dose administration of allogeneic mesenchymal stem cells to baboons. Cell Transplant, 15, pp. 711-721.
27. Zappia, E., Casazza, S. and Pedemonte, E. (2005) Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy. Blood, 106, pp. 1755-1761.
28. Ortiz, LA, Gambelli, F. and McBride, C. (2003) Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects. Proc Natl Acad Sci USA, 100, pp. 8407-8411.
29. Togel, F., Hu, Z. and Weiss, K. (2005) Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms. Am J Physiol Renal Physiol, 289, p. F31.
30. Ringden, O., Uzunel, M. and Rasmusson, I. (2006) Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease. Transplantation, pp. 1390-1397.
31. Blanc, K Le, Rasmusson, I. and Sundberg, B. (2004) Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. The Lancet, 363, pp. 1439-1441.
32. Kern, S., Eichler, H. and Stoeve, J. (2006) Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells, 24, pp. 1294-1301.
33. Stenderup, K., Justesen, J., Clausen, C. and Kassem, M. (2003) Aging is associated with decreased maximal life span and accelerated senescence of bone marrow stromal cells. Bone, 33, pp. 919-926.
34. Mitchell, JB, McIntosh, K. and Zvonic, S. (2006) Immunophenotype of human adipose-derived cells: Temporal changes in stromal-associated and stem cell-associated markers. Stem Cells, 24, pp. 376-385.
35. Puissant, B., Barreau, C. and Bourin, P. (2005) Immunomodulatory effect of human adipose tissue-derived adult stem cells: Comparison with bone marrow mesenchymal stem cells. Br J Haematol, 129, pp. 118-129.
36. Marshall, A. Vertebrate Embryology, Smith Elder and Co., London
37. Naeye, RL. (1985) Umbilical cord length: Clinical significance. J Pediatr, 107, pp. 278-281.
38. Wang, HS, Hung, SC and Peng, ST (2004) Mesenchymal stem cells in the Wharton's jelly of the human umbilical cord. Stem Cells, 22, pp. 1330-1337.
39. Bruder, SP, Jaiswal, N. and Ricalton, NS (1998) Mesenchymal stem cells in osteobiology and applied bone regeneration. Clin Orthop Relat Res, 355, p. S247.
40. Taupin, P. (2006) OTI-010 Osiris Therapeutics/JCR Pharmaceuticals. Curr Opin Investig Drugs, 7, pp. 473-481.
41. Zuk, PA, Zhu, M. and Ashjian, P. (2002) Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell, 13, pp. 4279-4295.
42. Kalman, L., Lindegren, ML and Kobrynski (2004) Mutations in genes required for T-cell development: IL7R, CD45, IL2RG, JAK3, RAG1, RAG2, ARTEMIS, and ADA and severe combined immunodeficiency: HuGE review. Genet Med, 6, pp. 16-26.
43. Huntington, ND and Tarlington, DM. (2004) CD45: Direct and indirect government of immune regulation. Immunol Lett, 94, pp. 167-174.
44. Dawes, R., Petrova, S. and Liu, Z. (2006) Combinations of CD45 isoforms are crucial for immune function and disease. J Immunol, 176, pp. 3417-3425.
45. McNeill, L., Salmon, RJ and Cooper, JC (2007) The differential regulation of Lck kinase phosphorylation sites by CD45 is critical for T cell receptor signaling responses. Immunity, 27, pp. 425-437.